Back to home

    Abbott (Ondo Tokenized Stock)

    ABTON

    Evaluation Score

    Overall rating on a scale of 0-10

    RiskReturn
    05.810
    Risk Level:
    Medium
    Recommendation:Hold
    Evaluated:August 28, 2026 (v14)

    Dimension Breakdown

    Development Activity6.5
    Community Health1.0
    Tokenomics7.0
    Market & Use Case5.5
    Team & Governance6.5
    Security & Audits7.5

    AI Analysis

    Comprehensive evaluation of the token

    ABTON is Abbott (Ondo Tokenized Stock), an RWA token offering on-chain economic exposure to Abbott Laboratories equity with automatic dividend reinvestment via Ondo Global Markets. Backed 1:1 by underlying shares and cash held with regulated custodians (BitGo, Alpaca Securities) and supported by third-party attestations, the product features clean security, no smart-contract exploits, and benefits from Ondo's broader institutional framework and Code4rena audits. However, the asset remains a micro-cap ($1.59M market cap, ~350 holders) with minimal liquidity, no dedicated community/governance rights, heavy centralization/single-issuer reliance, and pending regulatory clarity regarding tokenized stock structures (such as Ondo's April 2026 SEC no-action request). No qualifying red-flag events were identified, and the score reflects the exact weighted average across all categories.

    Development Activity

    Code updates and developer engagement

    RiskReturn
    06.510

    Community Support

    Social media presence and community engagement

    RiskReturn
    01.010

    Tokenomics

    Supply, distribution, and utility

    RiskReturn
    07.010

    Market & Use Case

    Value proposition and competitive landscape

    RiskReturn
    05.510

    Team & Governance

    Team background and project governance

    RiskReturn
    06.510

    Security & Audits

    Security history and audit status

    RiskReturn
    07.510

    About Abbott (Ondo Tokenized Stock) (ABTON)

    ABTON (Abbott (Ondo Tokenized Stock)) is a real-world asset (RWA) token issued by Ondo Finance through its Ondo Global Markets platform. It provides on-chain economic exposure to the equity of Abbott Laboratories (ABT) along with automatic dividend reinvestment. Deployed on both the Ethereum and Binance Smart Chain networks, the token is structured as a financial note under Swiss law and is backed 1:1 by underlying shares and cash reserves maintained by regulated custodians and broker-dealers, including BitGo and Alpaca Securities LLC.

    Governance and issuance mechanics for ABTON are centralized under Ondo Finance, led by founder and CEO Nathan Allman. Tokenholders receive economic exposure rather than direct corporate voting rights or shareholder privileges. The supply is backed against custody reserves, with minting and redemption operations conducted against USDC. While the individual token does not have an independent smart contract audit score, the platform's underlying tokenization infrastructure is covered by third-party security audits, including an April 2024 audit by Code4rena, an active Immunefi bug bounty program, and financial asset oversight by auditor BPM UK Audit Ltd alongside daily attestations by Ankura Trust Company.

    ABTON functions at a micro-cap scale with roughly $1.59 million in market capitalization and approximately 350 holders, resulting in limited on-chain trading volume and low DeFi liquidity. The project has recorded no hacks, smart contract exploits, or depegging events. The primary risks associated with the asset include single-issuer dependency, custodial counterparty reliance, and regulatory uncertainty. In April 2026, Ondo Finance submitted a no-action request to the U.S. Securities and Exchange Commission (SEC) Crypto Task Force concerning public blockchain recordkeeping for tokenized securities entitlements, reflecting the unresolved regulatory framework governing tokenized equities.

    Similar Rated Tokens